You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for New Drug Application (NDA): 020697


✉ Email this page to a colleague

« Back to Dashboard


NDA 020697 describes TASMAR, which is a drug marketed by Bausch and is included in one NDA. It is available from two suppliers. Additional details are available on the TASMAR profile page.

The generic ingredient in TASMAR is tolcapone. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the tolcapone profile page.
Summary for 020697
Tradename:TASMAR
Applicant:Bausch
Ingredient:tolcapone
Patents:0
Pharmacology for NDA: 020697
Suppliers and Packaging for NDA: 020697
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TASMAR tolcapone TABLET;ORAL 020697 NDA Bausch Health US LLC 0187-0938 0187-0938-01 90 TABLET, FILM COATED in 1 BOTTLE (0187-0938-01)
TASMAR tolcapone TABLET;ORAL 020697 NDA AUTHORIZED GENERIC Oceanside Pharmaceuticals 68682-938 68682-938-90 90 TABLET, FILM COATED in 1 BOTTLE (68682-938-90)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Jan 29, 1998TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength200MG
Approval Date:Jan 29, 1998TE:RLD:No

Expired US Patents for NDA 020697

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch TASMAR tolcapone TABLET;ORAL 020697-001 Jan 29, 1998 5,236,952 ⤷  Subscribe
Bausch TASMAR tolcapone TABLET;ORAL 020697-002 Jan 29, 1998 5,476,875 ⤷  Subscribe
Bausch TASMAR tolcapone TABLET;ORAL 020697-002 Jan 29, 1998 5,236,952 ⤷  Subscribe
Bausch TASMAR tolcapone TABLET;ORAL 020697-001 Jan 29, 1998 5,476,875 ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.